About the Company
NeurAxis, Inc
BUSINESS DESCRIPTION
NeurAxis is a growth stage company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children. NeurAxis is dedicated to advancing the science with its’ proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. We believe that superior science, evidence-based research, and building on its unparalleled body of clinical evidence is necessary for adoption by the medical...
NeurAxis, Inc News
-
NeurAxis, Inc. Announces Preferred Stock Dividend...
04/10/2026 11:00 AMCARMEL, Ind., April 10, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company comme...
-
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth...
03/24/2026 03:09 PMNRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability....
-
Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Oper...
03/19/2026 07:02 PMNeuraxis Inc (NRXS) reports a 27% revenue increase in Q4 2025, while navigating higher operating expenses and strategic expansions....
-
NeurAxis, Inc. Q4 2025 Earnings Call Summary...
03/19/2026 12:30 PMMoby summary of NeurAxis, Inc.'s Q4 2025 earnings call...
-
NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results...
03/19/2026 11:05 AMConference call will be held today, Thursday, March 19 at 9:00 am ETCARMEL, Ind., March 19, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “C...
-
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update C...
03/12/2026 01:00 PMCARMEL, Ind., March 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company comme...
-
NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, ...
01/08/2026 01:00 PMThe new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a Category I CPT® ...
-
Top Stock Reports for Meta, Bank of America & Procter & Gamble...
01/05/2026 09:34 PMMeta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and lingering concerns around monetization....
-
NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approxi...
12/19/2025 01:00 PMTotal national coverage footprint for PENFS increases to roughly 100 million covered livesCARMEL, Ind., Dec. 19, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“Neu...
Disclaimer: